Exercise recovery depends heavily on how well your muscles repair and replenish energy at the cellular level. Mitochondria, the organelles responsible for producing ATP, are central to that process. When mitochondria become damaged or dysfunctional after intense training, recovery slows and performance can suffer over time.
Urolithin A is a compound produced in the gut from polyphenols found in pomegranates, berries, and walnuts. It has drawn scientific attention for its ability to trigger mitophagy, a cellular cleanup process that removes damaged mitochondria and promotes renewal. Emerging research suggests this mechanism may have meaningful implications for muscle recovery, endurance, and long-term muscle health, though much of the evidence is still developing.
Key Takeaways
- Urolithin A is reported to trigger mitophagy in worm, cell and mouse studies [3][7][8]a cellular process that clears damaged mitochondria and supports energy production in muscle tissue.
- A randomized trial in 88 middle-aged adults missed its primary endpoint, peak power on a cycling test; hamstring strength and some biomarkers changed in secondary endpoints, and the trial was sponsored by Amazentis [1].
- A 2025 trial in highly trained distance runners assessed urolithin A’s effects on running performance and recovery, adding sport-specific data to the evidence base [2].
- Not everyone produces urolithin A efficiently from dietary sources; gut microbiome composition affects conversion, making supplemental forms more reliable for some individuals.
- The evidence is promising but still developing: more human trials across diverse populations are needed before firm conclusions can be drawn.
How Urolithin A Supports Mitochondrial Renewal
Mitophagy is the selective process by which cells identify and clear out damaged or dysfunctional mitochondria, allowing healthier mitochondria to take their place. Without adequate mitophagy, dysfunctional mitochondria accumulate and contribute to reduced energy output, increased oxidative stress, and slower muscle repair after exercise.
Urolithin A was identified as a potent mitophagy inducer in foundational research published in 2016, which demonstrated that it extended lifespan in C. elegans and improved muscle function in rodents [3]. These early findings established the biological rationale for studying urolithin A in the context of human muscle health and exercise.
More recent review work has highlighted mitochondria as nutritional targets relevant to physical function, noting that compounds capable of supporting mitochondrial quality control could have practical applications in exercise contexts and aging-related muscle decline [4].
Evidence from Human Clinical Trials
The most directly relevant human evidence comes from a randomized controlled trial published in 2022, which enrolled 88 middle-aged adults and assessed urolithin A over 4 months. The pre-specified primary endpoint, peak power output on a cycling test, did not change significantly versus placebo. Hamstring strength (a secondary endpoint) rose 12% and 9.8% in the two dose groups while the placebo group lost strength, and the trial was sponsored by Amazentis [1]. The trial did not measure mitophagy directly, so it does not link the animal mechanism to human outcomes [9][1].
Research note: In a pilot trial in 20 academy soccer players, there were no group-by-time differences in sprint speed, jump power, impulse, eccentric duration or saliva antioxidant assays [11].
A more recent trial published in 2025 examined urolithin A specifically in highly trained male distance runners: a population where mitochondrial efficiency and recovery between training sessions are especially relevant. The researchers assessed running performance, recovery markers, and mitochondrial biomarkers over the supplementation period [2]. While this study population differs from recreational exercisers, it provides some of the most sport-specific data available to date.
The result was mostly negative. In the 42 runners, the 3000 m time trial was not significantly improved by urolithin A, and the authors concluded it did not further enhance performance. Perceived exertion and a muscle-damage marker (creatine kinase) after the time trial were lower. The trial was supported by research funding from Amazentis [2].
Urolithin A in the Context of Sports Nutrition
A 2025 review in Frontiers in Nutrition examined the accumulating evidence on urolithin A specifically through a sports nutrition lens, attempting to bridge preclinical findings with potential athletic applications [5]. The review noted that while animal and cell-based research consistently supports urolithin A’s mitophagy-inducing and muscle-protective properties, translating those findings to athletic populations requires more controlled human trials with sport-specific endpoints.
The review also pointed to the challenge of bioavailability variability: urolithin A production from dietary precursors depends on an individual’s gut microbiome composition, meaning not everyone who consumes pomegranate or berry polyphenols will produce meaningful amounts. This variability has driven interest in direct urolithin A supplementation as a more reliable delivery method [5].
Muscle Health, Aging, and Recovery Capacity
Recovery capacity is not static: it tends to decline with age, partly because mitochondrial function and quality control processes become less efficient over time. Age-related muscle loss, or sarcopenia, is linked to mitochondrial dysfunction among other factors, and maintaining robust mitophagy may be one mechanism for preserving muscle health into later decades [6].
This aging dimension matters even for active individuals. No trial has compared recovery benefits between recreational, older and elite athletes, and in highly trained runners urolithin A did not further enhance performance [2]. The 2022 clinical trial, which focused on middle-aged adults rather than elite athletes, is relevant here: it reported strength and biomarker changes in secondary endpoints, but its primary performance endpoint, peak power, was not significantly changed [1].
Researchers have argued that nutritional strategies targeting mitochondrial quality are a legitimate and underexplored area for maintaining physical function across the lifespan, and that compounds like urolithin A fit within that framework [4].
What the Research Does and Does Not Show
It is important to be clear about the current state of evidence. The mechanistic case for urolithin A: that it induces mitophagy, supports mitochondrial health, and can improve certain muscle-related outcomes in humans) is supported by a plausible biological rationale and several published studies, though the main human trials were company-funded and missed their primary endpoints [1][10][3]. However, the number of high-quality randomized controlled trials in exercising humans remains limited.
The 2025 runner trial is a notable addition to the literature, but highly trained endurance athletes represent a narrow slice of the population, and findings may not generalize to all exercisers [2]. The 2025 review in Frontiers in Nutrition acknowledged this gap directly, calling for more robust human trials across diverse athletic populations before broad conclusions can be drawn [5].
The current evidence is promising enough to justify continued research and, for some individuals, to inform supplementation decisions in consultation with a healthcare provider. It is not sufficient to make definitive claims about performance gains or recovery timelines.
Practical Considerations for Exercisers
For those interested in urolithin A as part of a recovery strategy, the existing research used supplemental forms rather than dietary sources alone. This is partly because dietary polyphenol-to-urolithin A conversion varies widely between individuals based on gut microbiome composition: some people produce very little urolithin A from food regardless of intake [5].
Timing, dosage, and duration used in the published clinical trials varied, and optimal protocols for exercising populations have not been firmly established. The 2022 randomized trial used a specific daily dose over a defined supplementation period and reported strength and biomarker changes in secondary endpoints after missing its primary endpoint [1], but this should not be taken as a prescription. Anyone considering supplementation should review current product formulations and consult a healthcare provider, particularly if they have existing health conditions or take medications.
🛒 Where to Buy Urolithin A
- Timeline Mitopure SoftgelsClinically studied
softgels, 500 mg/day: The clinically studied form (Amazentis); used in the human trials. - Pure Encapsulations Renual
caplique capsules, 250 mg Mitopure Urolithin A/serving (with resveratrol + CoQ10): adds resveratrol and CoQ10, a combination the published urolithin A trials did not test. - ProHealth Longevity Urolithin A
capsules, 500 mg: Longevity-focused brand, often higher dose. - Double Wood Urolithin A
capsules, 250-500 mg: Budget-friendly, widely available, COA on request.
As an Amazon Associate we earn from qualifying purchases. Prices and availability vary; verify dose and third-party testing before buying.
A Note on the Evidence
The research on urolithin A and exercise recovery is promising but still early: most human trials are short-term, involve specific populations, and the field lacks large-scale long-term data. This article is for informational purposes only and does not constitute medical advice; consult a qualified healthcare provider before using urolithin A supplements, especially if you have a health condition or take medications.
Frequently Asked Questions
What is urolithin A and where does it come from?
Urolithin A is a compound produced in the gut when bacteria metabolize polyphenols found in foods like pomegranates, walnuts, and certain berries. Because its production depends on individual gut microbiome composition, not everyone makes meaningful amounts from diet alone [5].
How does urolithin A relate to exercise recovery?
Urolithin A is reported to induce mitophagy (the removal of damaged mitochondria) in worm, cell and mouse studies [3][7][8]which supports cellular energy production in muscle tissue. Since mitochondrial health is central to how muscles recover and perform after exercise, this mechanism is thought to underlie urolithin A’s potential recovery benefits [3].
Has urolithin A been tested in humans for muscle and exercise outcomes?
Yes. A randomized controlled trial in middle-aged adults missed its primary endpoint (peak power on a cycling test) and reported strength and biomarker changes in secondary endpoints [1]. A separate 2025 study also examined its effects in trained distance runners [2].
Is urolithin A relevant only for older adults?
Most of the available human evidence involves middle-aged or older adults, but research is expanding to include trained athletes [2]. No trial has compared effects by age group, so it is not known whether older exercisers benefit more [10], but the underlying mechanism, supporting mitochondrial quality control, is relevant across age groups [6].
Can I get enough urolithin A from food?
Possibly, but it depends on your gut microbiome. Not everyone efficiently converts dietary polyphenols into urolithin A, which is why researchers have increasingly focused on direct supplementation to ensure consistent delivery [5].
Is urolithin A safe, and are there any concerns?
The published clinical trials reported no significant safety concerns at the doses studied. However, long-term safety data in diverse populations is still accumulating. Anyone with a medical condition, those who are pregnant or breastfeeding, or anyone taking medications should consult a healthcare provider before starting any new supplement.
References
- Singh A et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell reports. Medicine (2022). PMID 35584623
- Whitfield J et al. Evaluating the Impact of Urolithin A Supplementation on Running Performance, Recovery, and Mitochondrial Biomarkers in Highly Trained Male Distance Runners. Sports medicine (Auckland, N.Z.) (2025). PMID 40839339
- Ryu D et al. Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nature medicine (2016). PMID 27400265
- Broome SC et al. Mitochondria as Nutritional Targets to Maintain Muscle Health and Physical Function During Ageing. Sports medicine (Auckland, N.Z.) (2024). PMID 39060742
- Wang M et al. Emerging evidence of Urolithin A in sports nutrition: bridging preclinical findings to athletic applications. Frontiers in nutrition (2025). PMID 40453722
- Dao T et al. Sarcopenia and Muscle Aging: A Brief Overview. Endocrinology and metabolism (Seoul, Korea) (2020). PMID 33397034
- Gao Z et al. Urolithin A protects against acetaminophen-induced liver injury in mice via sustained activation of Nrf2. International journal of biological sciences (2022). PMID 35342347
- Peter M. J. Quinn et al. PINK1/PARKIN signalling in neurodegeneration and neuroinflammation. Acta Neuropathologica Communications (2020). PMID 33168089
- Andreux PA et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nature metabolism (2019). PMID 32694802
- Liu S et al. Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial. JAMA network open (2022). PMID 35050355
- Monsalve Acevedo A et al. Effects of Urolithin A supplementation on performance and antioxidant status in academy soccer players during preseason: a pilot randomised controlled trial. Frontiers in nutrition (2025). PMID 41245402
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.